Innovative Endoscopy Components, LLC. which ADDvise signed a letter of intent to acquire on June 15, 2023, has during the subsequent due diligence not performed in line with initial expectations as regards profitability. ADDvise and the sellers have therefore agreed to terminate discussions.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Hanna Myhrman, General Counsel
+46 709 82 92 23
hanna.myhrman@addvisegroup.se
Important information
This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 22, 2023, at 17.35 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.